Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
Perplexing buyback from overvalued ASX share
stocks
Most popular shares in SMSFs
stocks
Will China strong arm BHP into lower iron ore prices?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,208.50 | 9.00 | -0.10% |
CAC 40 | 7,879.11 | 55.15 | -0.70% |
DAX 40 | 24,168.38 | 219.55 | -0.90% |
Dow JONES (US) | 46,067.58 | 587.98 | 1.29% |
FTSE 100 | 9,425.16 | 17.71 | -0.19% |
HKSE | 25,441.35 | 448.13 | -1.73% |
NASDAQ | 22,694.61 | 490.18 | 2.21% |
Nikkei 225 | 46,847.32 | 1,241.48 | -2.58% |
NZX 50 Index | 13,276.99 | 74.93 | -0.56% |
S&P 500 | 6,654.72 | 102.21 | 1.56% |
S&P/ASX 200 | 8,899.40 | 10.30 | -0.12% |
SSE Composite Index | 3,865.23 | 24.27 | -0.62% |